Table of Contents
1 INDUSTRY OUTLOOK 9
1.1 Industry overview 9
1.2 Total addressable market 9
1.3 Industry Trends 10
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 11
2.3 Research Methodology 12
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Market Definition - Infoholic Research 13
3.2 Importance of Companion diagnostics 13
3.3 Segmented Addressable Market (SAM) 13
3.4 Trends of the companion diagnostics market 14
3.5 Related Markets 15
3.5.1 Personalized medicine 15
3.5.2 Genetic testing Market 16
3.5.3 Point-Of-Care Diagnostics Market 16
4 Market Outlook 16
4.1 Overview 16
4.2 Regulatory Scenario 17
4.3 Market segmentation 18
4.4 PEST Analysis 18
4.5 Porter 5(Five) Forces 20
5 Market Characteristics 21
5.1 DRO - Global Companion Diagnostics Market Dynamics 21
5.1.1 Drivers 21
5.1.1.1 Growing incidence of cancer across the globe 21
5.1.1.2 Rising adoption of companion diagnostics tests 22
5.1.1.3 Growing demand of personalized medicine 23
5.1.2 Opportunities 23
5.1.2.1 Emerging applications of companion diagnostics 23
5.1.2.2 Growing demand for next-generation sequencing 23
5.1.3 Restraints 24
5.1.3.1 Uncertain reimbursement scenario in developed and developing countries 24
5.1.3.2 Lack of professionals to perform the test 25
6 Technology: Market Size and Analysis 27
6.1 Overview 27
6.2 Polymerase Chain Reaction 27
6.3 In Situ Hybridization 28
6.4 Immunohistochemistry 29
6.5 Next-Generation Sequencing 29
6.6 Others 30
7 Application: Market Size and Analysis 31
7.1 Overview 31
7.2 Cancer 31
7.2.1 Lung cancer 32
7.2.2 Breast cancer 33
7.2.3 Colorectal cancer 33
7.2.4 Melanoma 34
7.2.5 Others 34
7.3 Infectious disease 35
7.4 Others 35
8 End Users: Market Size and Analysis 36
8.1 Overview 36
8.2 Pharma and biopharma companies 36
8.3 Reference Laboratories 37
8.4 Others 37
9 Regions: Market Size and Analysis 37
9.1 Overview 38
9.2 North America 39
9.2.1 Overview 39
9.2.2 US 40
9.2.3 Canada 40
9.3 Europe 40
9.3.1 Overview 40
9.3.2 UK 41
9.3.3 Germany 42
9.3.4 France 42
9.3.5 Spain 42
9.4 APAC 42
9.4.1 Overview 42
9.4.2 India 43
9.4.3 China 44
9.5 Rest of the World 44
10 Competitive Landscape 46
10.1 Overview 46
11 Vendor Profiles 50
11.1 F.Hoffmann-La Roche Ltd 50
11.1.1 Overview 50
11.1.2 Business Unit 53
11.1.3 Geographic Presence 54
11.1.4 Business Focus 55
11.1.5 SWOT Analysis 55
11.1.6 Business Strategy 56
11.2 Qiagen N.V. 58
11.2.1 Overview 58
11.2.2 Geographic Presence 62
11.2.3 Business Focus 62
11.2.4 SWOT Analysis 63
11.2.5 Business Strategies 63
11.3 Abbott Laboratories 65
11.3.1 Overview 65
11.3.2 Business Unit 68
11.3.3 Geographic Presence 68
11.3.4 Business Focus 69
11.3.5 SWOT Analysis 70
11.3.6 Business Strategy 70
11.4 Myriad Genetics Inc. 72
11.4.1 Overview 72
11.4.2 Business Unit 74
11.4.3 Business Focus 75
11.4.4 SWOT Analysis 76
11.4.5 Business Strategy 76
11.5 Agilent Technologies Inc. 78
11.5.1 Overview 78
11.5.2 Business Units 81
11.5.3 Geographic Presence 82
11.5.4 Business Focus 83
11.5.5 SWOT Analysis 83
11.5.6 Business Strategies 84
12 Companies to Watch For 86
12.1 BioMerieux S.A. 86
12.1.1 Overview 86
12.1.2 BioMerieux S.A.: Recent Developments 86
12.2 Danaher Corporation (Leica Microsystems AG) 87
12.2.1 Overview 87
12.2.2 Danaher Corporation: Recent Developments 88
12.3 Resonance Health Limited 89
12.3.1 Overview 89
12.3.2 Resonance Health Limited: Recent Developments 89
12.4 Thermo Fisher Scientific 90
12.4.1 Overview 90
12.4.2 Thermo Fisher Scientific: Recent Developments 91
12.5 Genomic Health' Inc. 93
12.5.1 Overview 93
12.5.2 Genomic Health: Recent Developments 94
13 Annexure 96
13.1 Abbreviations 96